Chen Y et al. |
Structural Characterization of Cross-Linked Species in Trastuzumab Emtansine (Kadcyla). |
2016 |
Bioconjug. Chem. |
pmid:27458087
|
Ponte JF et al. |
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates. |
2016 |
Bioconjug. Chem. |
pmid:27174129
|
Widdison WC et al. |
Development of Anilino-Maytansinoid ADCs that Efficiently Release Cytotoxic Metabolites in Cancer Cells and Induce High Levels of Bystander Killing. |
2015 |
Bioconjug. Chem. |
pmid:26355774
|
Kellogg BA et al. |
Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkage. |
2011 |
Bioconjug. Chem. |
pmid:21425776
|
Nakao H et al. |
Cytotoxic activity of maytanprine isolated from Maytenus diversifolia in human leukemia K562 cells. |
2004 |
Biol. Pharm. Bull. |
pmid:15305028
|
Zhong P et al. |
Glutathione-Sensitive Hyaluronic Acid-SS-Mertansine Prodrug with a High Drug Content: Facile Synthesis and Targeted Breast Tumor Therapy. |
2016 |
Biomacromolecules |
pmid:27723970
|
Bellat V et al. |
Smart Nanotransformers with Unique Enzyme-Inducible Structural Changes and Drug Release Properties. |
2016 |
Biomacromolecules |
pmid:27180972
|
Arai MA et al. |
Hedgehog/GLI-mediated transcriptional inhibitors from Zizyphus cambodiana. |
2008 |
Bioorg. Med. Chem. |
pmid:18842418
|
Nittoli T et al. |
Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids. |
2018 |
Bioorg. Med. Chem. |
pmid:29605304
|
Lin J and Zhong JJ |
Proteomic studies on anti-tumor agent ansamitocin P-3 producer Actinosynnema pretiosum in response to ammonium and isobutanol. |
2017 |
Bioprocess Biosyst Eng |
pmid:28382459
|
Lin J et al. |
Enhanced production of ansamitocin P-3 by addition of isobutanol in fermentation of Actinosynnema pretiosum. |
2011 |
Bioresour. Technol. |
pmid:20980145
|
Jia Y and Zhong JJ |
Enhanced production of ansamitocin P-3 by addition of Mg2+ in fermentation of Actinosynnema pretiosum. |
2011 |
Bioresour. Technol. |
pmid:21907573
|
Ning X et al. |
Identification and Engineering of Post-PKS Modification Bottlenecks for Ansamitocin P-3 Titer Improvement in Actinosynnema pretiosum subsp. pretiosum ATCC 31280. |
2017 |
Biotechnol J |
pmid:28881098
|
Du ZQ et al. |
Combination of traditional mutation and metabolic engineering to enhance ansamitocin P-3 production in Actinosynnema pretiosum. |
2017 |
Biotechnol. Bioeng. |
pmid:28782796
|
Oki T |
Cytotoxic and antitumor antibiotics produced by microorganisms. |
1980 |
Biotechnol. Bioeng. |
pmid:6159010
|
Tassone P et al. |
Cytotoxic activity of the maytansinoid immunoconjugate B-B4-DM1 against CD138+ multiple myeloma cells. |
2004 |
Blood |
pmid:15292058
|
Matsubara Y |
A Meg by any other name. |
2012 |
Blood |
pmid:22956528
|
Thon JN et al. |
High-content live-cell imaging assay used to establish mechanism of trastuzumab emtansine (T-DM1)--mediated inhibition of platelet production. |
2012 |
Blood |
pmid:22665936
|
Deckert J et al. |
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies. |
2013 |
Blood |
pmid:24002446
|
Palomba ML and Younes A |
In the spotlight: a novel CD37 antibody-drug conjugate. |
2013 |
Blood |
pmid:24235129
|